BRPI0412224A - uso de cloreto do sódio, cloreto de sódio, emplastro, dispositivo, preparado e método de manufatura de um medicamento - Google Patents

uso de cloreto do sódio, cloreto de sódio, emplastro, dispositivo, preparado e método de manufatura de um medicamento

Info

Publication number
BRPI0412224A
BRPI0412224A BRPI0412224-0A BRPI0412224A BRPI0412224A BR PI0412224 A BRPI0412224 A BR PI0412224A BR PI0412224 A BRPI0412224 A BR PI0412224A BR PI0412224 A BRPI0412224 A BR PI0412224A
Authority
BR
Brazil
Prior art keywords
sodium chloride
plaster
medicament
manufacture
preparation
Prior art date
Application number
BRPI0412224-0A
Other languages
English (en)
Inventor
Warren Ward
Original Assignee
Warren Ward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0316940A external-priority patent/GB0316940D0/en
Application filed by Warren Ward filed Critical Warren Ward
Publication of BRPI0412224A publication Critical patent/BRPI0412224A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C01G23/04—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/06—Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"USO DE CLORETO DE SóDIO, CLORETO DE SóDIO, EMPLASTRO, DISPOSITIVO, PREPARADO E MéTODO DE MANUFATURA DE UM MEDICAMENTO". A presente invenção refere-se a agentes medicinalmente eficazes revestidos com uma substância que forma uma camada impermeável a líquido, mas permeável a gás, ao tratamento de condições médicas com os mesmos e particularmente das condições médicas pelo menos parcialmente caracterizadas pela obstrução ou outro mau funcionamento dos dutos das glândulas exócrinas e especialmente dos dutos das glândulas sudoríparas.
BRPI0412224-0A 2003-07-19 2004-07-19 uso de cloreto do sódio, cloreto de sódio, emplastro, dispositivo, preparado e método de manufatura de um medicamento BRPI0412224A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0316940A GB0316940D0 (en) 2003-07-19 2003-07-19 Treatment of skin and other medical conditions
GB0327006A GB0327006D0 (en) 2003-07-19 2003-11-20 Drug compositon and therapeutics
PCT/GB2004/003104 WO2005013942A1 (en) 2003-07-19 2004-07-19 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases

Publications (1)

Publication Number Publication Date
BRPI0412224A true BRPI0412224A (pt) 2006-08-22

Family

ID=34137742

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412224-0A BRPI0412224A (pt) 2003-07-19 2004-07-19 uso de cloreto do sódio, cloreto de sódio, emplastro, dispositivo, preparado e método de manufatura de um medicamento

Country Status (9)

Country Link
US (2) US20060159776A1 (pt)
EP (1) EP1656120B1 (pt)
JP (1) JP2007516948A (pt)
KR (1) KR101231542B1 (pt)
AU (1) AU2004262969B2 (pt)
BR (1) BRPI0412224A (pt)
CA (1) CA2532344A1 (pt)
PL (1) PL1656120T3 (pt)
WO (1) WO2005013942A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914891B2 (en) 2005-12-28 2011-03-29 Kimberly-Clark Worldwide, Inc. Wipes including microencapsulated delivery vehicles and phase change materials
US7442439B2 (en) 2005-12-28 2008-10-28 Kimberly-Clark Worldwide, Inc. Microencapsulated heat delivery vehicles
US20070148448A1 (en) * 2005-12-28 2007-06-28 Kimberly-Clark Worldwide, Inc. Microencapsulated delivery vehicles including cooling agents
US7497351B2 (en) 2006-05-30 2009-03-03 Kimberly-Clark Worldwide, Inc. Wet wipe dispensing system
US7654412B2 (en) 2006-05-30 2010-02-02 Kimberly-Clark Worldwide, Inc. Wet wipe dispensing system for dispensing warm wet wipes
US7597954B2 (en) 2006-12-14 2009-10-06 Kimberly-Clark Worldwide, Inc. Supersaturated solutions using crystallization enthalpy to impact temperature change to wet wipes
US7517582B2 (en) 2006-12-14 2009-04-14 Kimberly-Clark Worldwide, Inc. Supersaturated solutions using crystallization enthalpy to impart temperature change to wet wipes
US8192841B2 (en) 2006-12-14 2012-06-05 Kimberly-Clark Worldwide, Inc. Microencapsulated delivery vehicle having an aqueous core
AU2013209343B1 (en) * 2013-05-14 2014-04-24 Activesignal Holding Limited Device for the Treatment of Bone Conditions
CN110665109A (zh) * 2019-10-29 2020-01-10 延安康亿健医药科技有限公司 明目护眼贴

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2119244A (en) * 1982-04-30 1983-11-16 Alza Corp Potassium replacement therapy
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
EP0711146B1 (en) * 1993-07-22 2000-09-06 Pfizer Inc. Osmotic device having a vapor-permeable coating
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
WO2003005995A1 (en) 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide

Also Published As

Publication number Publication date
WO2005013942A1 (en) 2005-02-17
JP2007516948A (ja) 2007-06-28
AU2004262969B2 (en) 2010-08-12
EP1656120B1 (en) 2012-11-28
US20130142851A1 (en) 2013-06-06
KR101231542B1 (ko) 2013-02-07
AU2004262969A1 (en) 2005-02-17
US20060159776A1 (en) 2006-07-20
CA2532344A1 (en) 2005-02-17
PL1656120T3 (pl) 2013-04-30
EP1656120A1 (en) 2006-05-17
KR20060034295A (ko) 2006-04-21

Similar Documents

Publication Publication Date Title
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
CY1110376T1 (el) Χρηση μιας συνθεσης που περιλαμβανει φορμοτερολη και βουδεσονιδη για την προληψη απο ή τη θεραπευτικη αντιμετωπιση μιας οξειας καταστασης ασθματος
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
BR0013667A (pt) Derivados de glucopiranosiloxipirazol, composições medicinais contendo os mesmos derivados e seus intermediários na produção dos mesmos
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
BR0011891A (pt) Composto, composição farmacêutica, uso de um composto, métodos para tratamento de uma doença ou condição mediada pelo hpparso , para diminuir triglicerìdios em um paciente, para tratar a diabete do tipo 2, diminuir a resistência à insulina ou abaixar a pressão sanguìnea em um paciente, para diminuir os nìveis de fribogênio em um paciente, para diminuir o ldlc em um paciente e para mudar o tamanho da partìcula do ldl denso pequeno para denso normal em um paciente, e , uso de uma agonista hpparso
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
BRPI0621170B8 (pt) pó hesmostático, bandagem hesmostática para feridas e método de manufatura de um pó hesmostático
DE69017654D1 (de) Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
BR0314943A (pt) Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
DE60232077D1 (de) Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten
CO2021013251A2 (es) Derivados de insulina sensibles a la glucosa
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
NO20050569L (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
DE60118019D1 (de) Zusammensetzung enthaltend hydroxyzitronensäure und garcinol zur gewichtsreduzierung
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
MX2009011900A (es) Curacion de herida diabetica.
BR0109602A (pt) Glóbulos de liberação controlada contendo estavudina
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
TR200002969T2 (tr) Farmasötik bileşim.
BRPI0916282B8 (pt) uso de um agonista do receptor-pgi2 no tratamento de insuficiência renal crônica
DE50114474D1 (de) Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
WO2009041111A1 (ja) 経口投与剤

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 9/50, A61K 9/70, A61K 33/14, A61K 31/60, A61K 31/155, A61P 17/00

Ipc: A61K 9/50 (2011.01), A61K 9/70 (2011.01), A61K 33/

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]